Popular Trials
Hormone Therapy
Hormone Withdrawal for Depression
Recruiting2 awardsPhase 4
Chapel Hill, North Carolina
"This trial aims to understand how hormonal changes during the menstrual cycle impact mood symptoms in women with depression that worsens before menstruation. They will investigate how estrogen and progesterone levels affect pleasure and reward
Chemotherapy
Chemotherapy + HER2-Targeted Therapy With or Without Hormone Therapy for Breast Cancer
Recruiting4 awardsPhase 3
Fairbanks, Alaska
This trial is studying a combination of drugs given with or without hormone therapy to see how well they work in treating patients with hormone receptor-positive, HER2-positive breast cancer.
Popular Filters
Trials for Breast Cancer Patients
Hormone Therapy
Ovarian Suppression + Tamoxifen/Exemestane for Breast Cancer
Recruiting4 awardsPhase 3
Birmingham, Alabama
This trial is testing whether suppressing ovarian function and combining it with either tamoxifen or exemestane is more effective than tamoxifen alone in treating premenopausal women with hormone-responsive breast cancer.
Trials for LABC Patients
Hormone Therapy
Ovarian Suppression + Tamoxifen/Exemestane for Breast Cancer
Recruiting4 awardsPhase 3
Birmingham, Alabama
This trial is testing whether suppressing ovarian function and combining it with either tamoxifen or exemestane is more effective than tamoxifen alone in treating premenopausal women with hormone-responsive breast cancer.
Trials for ER Positive Patients
Selective Estrogen Receptor Modulator
Endoxifen for Hormone-Receptor-Positive Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing the safety and effectiveness of the drug endoxifen in individuals with hormone receptor positive solid tumors. Eligible participants must be 18 years or older and have had at least one prior chemotherapy and hormonal regimen for metastatic disease.
Hormone Therapy
Ovarian Suppression + Tamoxifen/Exemestane for Breast Cancer
Recruiting4 awardsPhase 3
Birmingham, Alabama
This trial is testing whether suppressing ovarian function and combining it with either tamoxifen or exemestane is more effective than tamoxifen alone in treating premenopausal women with hormone-responsive breast cancer.
Trials for PR Positive Patients
Selective Estrogen Receptor Modulator
Endoxifen for Hormone-Receptor-Positive Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing the safety and effectiveness of the drug endoxifen in individuals with hormone receptor positive solid tumors. Eligible participants must be 18 years or older and have had at least one prior chemotherapy and hormonal regimen for metastatic disease.
Hormone Therapy
Ovarian Suppression + Tamoxifen/Exemestane for Breast Cancer
Recruiting4 awardsPhase 3
Birmingham, Alabama
This trial is testing whether suppressing ovarian function and combining it with either tamoxifen or exemestane is more effective than tamoxifen alone in treating premenopausal women with hormone-responsive breast cancer.
Phase 3 Trials
Hormone Therapy
Ovarian Suppression + Tamoxifen/Exemestane for Breast Cancer
Recruiting4 awardsPhase 3
Birmingham, Alabama
This trial is testing whether suppressing ovarian function and combining it with either tamoxifen or exemestane is more effective than tamoxifen alone in treating premenopausal women with hormone-responsive breast cancer.
CDK4/6 Inhibitor
Abemaciclib + Fulvestrant for Breast Cancer
Recruiting3 awardsPhase 3
Fayetteville, Arkansas
This trial is comparing two treatments for hormone receptor positive, HER2 negative advanced breast cancer. One group will receive abemaciclib + fulvestrant, and the other will just receive fulvestrant. The study will last about 9 months for each participant.
Trials With No Placebo
Behavioural Intervention
Neural and Hormonal Influences on Alcohol Use Disorder Risk
Recruiting3 awards5 criteria
Lexington, Kentucky
This trial is looking at the neural and hormonal factors that contribute to why women are more at risk for AUD than men. They will be looking at three addiction domains: inhibitory control (executive function), negative emotionality, and alcohol cue reactivity (incentive salience).
Hormone Therapy
Hormone Therapy + Radiation for Prostate Cancer
Recruiting3 awards5 criteria
Chicago, Illinois
This trial is testing if taking hormone pills can improve the quality of life and survival rates for patients who need hormone-based treatment. The pills work by adjusting hormone levels in the body to help manage their condition.
Selective Estrogen Receptor Modulator
Endoxifen for Hormone-Receptor-Positive Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing the safety and effectiveness of the drug endoxifen in individuals with hormone receptor positive solid tumors. Eligible participants must be 18 years or older and have had at least one prior chemotherapy and hormonal regimen for metastatic disease.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.